Elevation Oncology, Inc. - COM (ELEV)

Historical Portfolio Holders from Q2 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
52.1M
Holdings value Q2 2024
$140M
Value change Q2 2024
+$17.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
79
Number of buys Q2 2024
51
Number of sells Q2 2024
-32
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 52.1M $140M +$17.1M $2.70 79
2024 Q1 44M $226M +$110M $5.13 61
2023 Q4 25.8M $13.9M -$1.44M $0.54 31
2023 Q3 28M $18.6M -$4.59M $0.66 40
2023 Q2 31.5M $47.9M +$22.1M $1.52 37
2023 Q1 16.2M $30.8M +$3.71M $1.90 26
2022 Q4 14.4M $13.7M +$99K $0.95 25
2022 Q3 14.3M $16.1M -$1.53M $1.13 20
2022 Q2 15M $21M -$7.07M $1.40 21
2022 Q1 18.7M $47.2M +$631K $2.52 27
2021 Q4 18.3M $110M -$3.12M $6.02 34
2021 Q3 15.9M $123M -$8.12M $7.79 21
2021 Q2 16.2M $217M +$217M $13.57 36